+254.2%
MRNA vs ACGL
+33.2%
+221.0%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | ACGL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.9% | 0.0% | -0.9% | -0.9% |
| 7D | -3.8% | -1.4% | -2.4% | -3.9% |
| 30D | +16.4% | +12.4% | +4.0% | +17.7% |
| 3M | +310.6% | +11.1% | +299.5% | +315.1% |
| 6M | +370.3% | +16.3% | +353.9% | +375.4% |
| YTD | +743.3% | +13.8% | +729.5% | +751.1% |
| 1Y | +841.7% | +20.4% | +821.2% | +846.1% |
| All | +254.2% | +33.2% | +221.0% | +258.3% |
Cumulative growth
Daily Returns
Daily percentage return beside ACGL.
Daily Out/Under-Performance
Portfolio return minus ACGL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ACGL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded ACGL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling